ETF Building Blocks Content Hub Steady Rate Cuts Feed Surging Biotech ETF SBIO By Nick Peters-GoldenNovember 13, 2024
ETF Building Blocks Content Hub How Election Results Could Impact Biotech ETFs By Todd ShriberNovember 12, 2024
ETF Building Blocks Content Hub Biotech ETF SBIO Laps Tech Rivals Over 1 Year By Nick Peters-GoldenOctober 22, 2024
ETF Building Blocks Content Hub Biotech Stocks Are Perking Up. This ETF Is Responding By Todd ShriberSeptember 4, 2024
ETF Building Blocks Content Hub Biotech ETF SBIO Rides Strong Momentum Into Rate Cuts By Nick Peters-GoldenAugust 29, 2024
ETF Building Blocks Content Hub Positive Biotech M&A Activity in 1H Boosts Case for Biotech ETF SBIO By Nick Peters-GoldenAugust 19, 2024
ETF Building Blocks Content Hub Returns Spiking for This Rate-Sensitive ETF By Nick Peters-GoldenJuly 19, 2024
Leveraged & Inverse Content Hub Early IPO Activity Could Spell Bullishness for Biotech Industry By Ben HernandezJanuary 26, 2024
ETF Building Blocks Content Hub Biotech ETF SBIO’s Momentum Strong to End 2023 By Nick Peters-GoldenDecember 28, 2023
ETF Building Blocks Content Hub Play US Gene Treatment Approval in SBIO By Nick Peters-GoldenDecember 7, 2023
Modern Alpha Content Hub Multiple Reasons to Bet on Biotech ETF WDNA By Todd ShriberSeptember 25, 2023
Leveraged & Inverse Content Hub 3 Trades to Consider Amid Early Summer Rally By Ben HernandezJuly 6, 2023
Beyond Basic Beta Content Hub Bull vs. Bear: How Healthy Are Biotech ETFs? By The VettaFi WritersMay 10, 2023
Disruptive Technology Content Hub Rising Biotech ETF HTEC Signaling a Buy By Nick Peters-GoldenMay 3, 2023
ETF Building Blocks Content Hub ALPS’ Biotech ETF SBIO Week’s Top Performer By Nick Peters-GoldenApril 24, 2023
ETF Building Blocks Content Hub Biotech ETFs’ Performance Deserves A Look By Nick Peters-GoldenApril 19, 2023
Disruptive Technology Content Hub Eye DNA Synthesis Advances in Active Biotech ETF ARKG By Nick Peters-GoldenFebruary 1, 2023
Disruptive Technology Content Hub EXAS Nears Key Buy Signal in Active Biotech ETF ARKG By Nick Peters-GoldenJanuary 11, 2023